3 ms·
To be completely honest I don't 100% trust the medical industry whenever there's so much money behind marketing something. There's a very real vested interest i
by 999900000999 10mo ago
To be completely honest I don't 100% trust the medical industry whenever there's so much money behind marketing something. There's a very real vested interest in trying to downplay the risk factors because let's just say tomorrow they found out this stuff makes all your teeth fall out.
A whole lot of folks would lose billions of dollars. My first instinct is to think I need to go and take another Europe. The food is better there and I lost a good amount of weight the first time.
- Someone1234 10mo agoUnderstood. You may be interested to learn that Liraglutide, a GLP-1 Agonist, has been commercially available and commonly used since 2010 (15-years+) without any unknown/unexpected additional side-effects appearing. It was developed in 1998. The main reason GLP-1 Agonists are suddenly more popular is two things: - Liraglutide had to be taken daily, instead of weekly. - Nobody every paid for Liraglutide to be clinically approved for weight-loss. It was an anti-diabetic medication; but the mechanism of action is the same. Compared with liraglutide, semaglutide was engineered mainly with a longer, differently attached fatty-acid side chain that increases albumin binding and slows clearance, so it lasts longer; both drugs activate the GLP-1 receptor.
- array_key_first 10mo agoTo be fair, if this stuff did make your teeth fall out, that would still be worth it. Everything is risk calculus. If you're just a bit overweight, then yeah probably not worth the risk. If you're morbidly obese then it's a no brainer. I will say this: the bar for obesity is lower than most people think.